Spire Wealth Management Has $3.68 Million Position in HCA Healthcare, Inc. $HCA

Spire Wealth Management raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 20.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,629 shares of the company’s stock after purchasing an additional 1,447 shares during the period. Spire Wealth Management’s holdings in HCA Healthcare were worth $3,678,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Ameriflex Group Inc. bought a new position in HCA Healthcare in the second quarter worth approximately $27,000. Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth $27,000. Clearstead Trust LLC increased its stake in HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in shares of HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth about $40,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on HCA. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Royal Bank Of Canada lifted their price objective on shares of HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a report on Friday, December 19th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a report on Wednesday. Sanford C. Bernstein reissued a “market perform” rating and set a $503.00 target price on shares of HCA Healthcare in a research report on Tuesday. Finally, Robert W. Baird increased their price target on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Fourteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $485.95.

HCA Healthcare Trading Up 1.8%

HCA Healthcare stock opened at $479.29 on Friday. The company has a market cap of $109.37 billion, a price-to-earnings ratio of 18.53, a PEG ratio of 1.29 and a beta of 1.36. The business’s 50 day simple moving average is $479.63 and its 200 day simple moving average is $426.40. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the prior year, the firm earned $4.90 EPS. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.